Antidepressants: controversies about their efficacy in depression, their effect on suicidality and their place in a complex psychiatric treatment approach (Q37539807)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2009

Language	Label	Description	Also known as
English	Antidepressants: controversies about their efficacy in depression, their effect on suicidality and their place in a complex psychiatric treatment approach	scientific article published on January 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

1 reference

Europe PubMed Central

Antidepressants: controversies about their efficacy in depression, their effect on suicidality and their place in a complex psychiatric treatment approach (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

0 references

suicide prevention

0 references

0 references

Hans-Jürgen Möller

1

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

180-195

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention.

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Placebo-controlled studies in depression: necessary, ethical and feasible

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Major Depressive Disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Gene-environment interactions in psychiatry: joining forces with neuroscience

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Behavioral activation treatments of depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Problem solving therapies for depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Short psychodynamic supportive psychotherapy, antidepressants, and their combination in the treatment of major depression: a mega-analysis based on three randomized clinical trials

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Evidence of agomelatine's antidepressant efficacy: the key points

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Design of clinical trials of antidepressants: should a placebo control arm be included?

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Neuroimaging genetics: new perspectives in research on major depression?

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Suicidality in pediatric patients treated with antidepressant drugs

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Should combined pharmaco- and psychotherapy be offered to depressed patients? A qualitative review of randomized clinical trials from the 1990s

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Molecular genetics of bipolar disorder and depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Rationale and options for the long-term treatment of depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Interpersonal psychotherapy (IPT) and drugs in the treatment of depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Sertraline versus imipramine to prevent relapse in chronic depression.

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Efficacy of escitalopram in patients with severe depression: a pooled analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

A regulatory Apologia--a review of placebo-controlled studies in regulatory submissions of new-generation antidepressants

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Antidepressants--do they decrease or increase suicidality?

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Rating depressed patients: observer- vs self-assessment

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Is there a need for a new psychiatric classification at the current state of knowledge?

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Isn't the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008.

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Standardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Self-rating procedures in the evaluation of antidepressants

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Prediction of therapeutic response in acute treatment with antidepressants. Results of an empirical study involving 159 endogenous depressive inpatients

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Efficacy of antidepressants in adults

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Which antidepressants have demonstrated superior efficacy? A review of the evidence

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Classifying depression: should paradigms lost be regained?

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Differential effectiveness of newer and older antidepressants appears mediated by an age effect on the phenotypic expression of depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Cognitive therapy in relapse prevention in depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Escitalopram versus citalopram: the surprising role of the R-enantiomer

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Innovative approaches for the development of antidepressant drugs: current and future strategies

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Genetic epidemiology of major depression: review and meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Antidepressant drugs and the emergence of suicidal tendencies

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Effect of telephone contact on further suicide attempts in patients discharged from an emergency department: randomised controlled study

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions

1 reference

https://api.crossref.org/works/10.1080%2F15622970903101665

21 January 2018

Identifiers

10.1080/15622970903101665

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37539807&oldid=2229388124"